3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Recurrence
13
Multiple Myeloma
12
Lymphoma, B-Cell
12
Lymphoma, Non-Hodgkin
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Ovarian Neoplasms
7
Lymphoma
7
Burkitt Lymphoma
7
Melanoma
5
Lymphoma, Mantle-Cell
5
Hematologic Neoplasms
5
Nasopharyngeal Carcinoma
4
Myelodysplastic Syndromes
4
Lymphoma, T-Cell
4
Leukemia
3
Graft vs Host Disease
3
Uterine Cervical Neoplasms
2
Sarcoma, Synovial
2
Neuroblastoma
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Leukemia, T-Cell
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Glioblastoma
2
Interventions
fludarabine
1
Endostatins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Adenoviridae Infections
×
fludarabine
×
Clear all
NCT00625430
2011-07-11
FP253-GDEPT
Biotech Equity Partners Pty Ltd
Phase 1
Unknown
18 enrolled